晚期远端I型内漏的规划与移植物相关预测因素
该研究前瞻性收集2008至2013年接受择期EVAR的AAA患者,回顾性分析晚期远端I型内漏(ELIB)的发生率、表现、治疗及解剖和技术预测因素。多变量分析显示髂支直径oversizing<10%和远端锚定区距髂内动脉开口>1 cm是独立危险因素。
要点
- EVAR术后晚期远端I型内漏发生率2.3%,中位随访32.8个月。
- 髂支oversizing<10%和远端锚定>1 cm是独立预测因素。
- 多数ELIB可通过髂支延伸的血管腔内治疗处理。
核心结论
- ELIB是EVAR长期随访中不可忽视的并发症,常需再次干预,多采用血管腔内解决方案。
- 建议髂支直径oversizing>10%并减少髂总动脉覆盖(距髂内动脉开口<1 cm)以预防ELIB。
研究设计与样本
- 前瞻性收集2008至2013年择期EVAR患者,回顾性筛选晚期ELIB(G1)并与无ELIB对照组(G2)比较。
- ELIB定义为术后6个月后出现远端I型内漏,且术中完成造影和术后CTA均无内漏。
- G1共14例,G2共30例,G2在临床条件、移植物和随访时间上与G1匹配,最低随访24个月。
主要发现
- 14例中3例有症状(AAA破裂2例,疼痛1例),11例无症状于常规随访发现。
- 治疗:1例开放修复,13例血管腔内髂支延伸;2例需髂内动脉闭塞。
- G2中位随访41.2个月(IQR 25)。
临床怎么用
- EVAR规划时应确保髂支直径oversizing>10%。
- 远端锚定应尽量靠近髂内动脉开口(<1 cm),避免过多覆盖髂总动脉。
- 长期随访中需警惕无症状性ELIB,及时干预。
局限性
- 回顾性选择ELIB病例,样本量小(G1 14例,G2 30例)。
- 单中心经验,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Late distal type I endoleak (ELIB) hampers the outcome of endovascular repair (EVAR) for abdominal aortic aneurysm (AAA); however, only few dedicated experiences have been reported in the literature. The aim of the study was to evaluate the incidence, presentation and treatment of late ELIB and to identify possible anatomical and technical predictors. METHODS: All patients undergoing elective EVAR between 2008 and 2013 were collected prospectively. Follow up was by post-operative computed tomography angiography (CTA) performed within 30 days and CTA and/or duplex ultrasound (DUS) at six or 12 months and yearly thereafter. Patients with late ELIB, defined as distal type I endoleak detected more than six months after the primary intervention without endoleak on the intra-operative completion angiogram and on the post-operative CTA, were retrospectively selected (G1) and compared with a control group with no ELIB (G2) homogeneous for clinical conditions, endograft implanted, and timing of follow up. The minimum follow up required for inclusion in the study was 24 months. Pre-operative morphological aorto-iliac features and EVAR implant details were evaluated, and measurements performed after centre lumen line reconstructions using dedicated software. The differences between G1 and G2 were analysed using the chi-square test, the Student t test, and logistic regression. RESULTS: Six hundred and sixteen patients were submitted to EVAR. ELIB was detected in 14 cases (2.3%) (G1) at a median follow up of 32.8 (IQR 48) months. In three of the 14 cases ELIB was symptomatic (AAA rupture, 2; pain, 1); in the remaining 11 cases it was asymptomatic and found incidentally at routine follow up. Treatment was by open repair in one case and by endovascular iliac leg extension in 13 cases. Hypogastric exclusion was necessary in two of 14 cases. Thirty patients were included in G2, with a median follow up of 41.2 (25) months. Common iliac artery length <4 cm (OR 5.3, 95% CI 1.1-29.5, p = .05), diameter > 15 mm (OR 3.5, 95% CI 1.2-10.9, p = .03), and severe thrombotic apposition (>50% of circumference) (OR 5, 95% CI 1.2-19.2, p = .02), at the iliac sealing zone were significant predictors of ELIB, on univariable analysis; oversizing of the iliac leg diameter < 10% and distal sealing > 1 cm above the hypogastric origin were independently associated with ELIB (OR 5.4, 95% CI 1.3-21.5, p = .01 and OR 6.6, 95% CI 1.1-39.3, p = .03, respectively), on multivariable analysis. CONCLUSION: The present data underline that ELIB is a non-negligible occurrence during long term EVAR follow up and requires further interventions, most often by endovascular solutions. According to the ELIB risk factors identified in this study, an iliac leg diameter oversize >10% and extensive common iliac artery coverage (<1 cm above the hypogastric origin) would be suggested to prevent this complication.
引用
- Mascoli C, Faggioli G, Gallitto E, et al. Planning and Endograft Related Variables Predisposing to Late Distal Type I Endoleaks. Eur J Vasc Endovasc Surg. 2019. PMID: 31358363. doi:10.1016/j.ejvs.2019.03.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。